If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

The focus of my research over the past few years has been on Alzheimer’s disease and the identification of blood-based biomarkers that can be used in the early diagnosis of the disease. I have focused on investigating risk factors for cognitive decline and dementia in the Mexican-American elderly. I have also investigated the occurrence and identification of factors leading to neuropsychiatric symptoms of Alzheimer’s such as depression, anxiety, and inappropriate behavior. Alzheimer’s is a major public health concern, and developing accessible means to predict the disease and potentially allow for intervention to prevent or slow the disease is of upmost importance. Additionally, being able to identify those with the disease who are most likely to develop neuropsychiatric symptoms (the primary cause of caregiver stress and nursing home placement) can lead to early intervention and provide the groundwork for understanding the pathophysiology of neuropsychiatric symptoms of dementia. Developing treatment approaches for the pre-clinical stage of Alzheimer’s disease to reduce the risk of developing neurodegenerative diseases is crucial to our aging population.

Education/Academic qualification

PhD in Clinical Psychology, University of Nevada, Reno

BA in History, University of Iowa

Fingerprint Dive into the research topics where James Hall is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Dementia Medicine & Life Sciences
Depression Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Cognition Medicine & Life Sciences
Hispanic Americans Medicine & Life Sciences
Endophenotypes Medicine & Life Sciences
Neuropsychological Tests Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2022

Research Output 2006 2019

  • 1463 Citations
  • 19 h-Index
  • 71 Article
  • 2 Review article
  • 1 Short survey
1 Citation (Scopus)

A proteomic signature for dementia with Lewy bodies

O'Bryant, S., Ferman, T. J., Zhang, F., Hall, J., Pedraza, O., Wszolek, Z. K., Como, T., Julovich, D., Mattevada, S., Johnson, L. A., Edwards, M. & Graff-Radford, N. R., 1 Dec 2019, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 270-276 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Lewy Body Disease
Proteomics
Parkinson Disease
Dementia
Sensitivity and Specificity

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study

O'Bryant, S., Edwards, M., Zhang, F., Johnson, L. A., Hall, J., Kuras, Y. & Scherzer, C. R., 1 Dec 2019, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 11, p. 374-382 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Neurodegenerative Diseases
Proteomics
Parkinson Disease
Biomarkers
Alzheimer Disease

The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort

Vintimilla, R., Hall, J., Johnson, L. A. & O'Bryant, S., 1 May 2019, In : Medicine. 98, 19, p. e15605

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Hispanic Americans
C-Reactive Protein
Cognition
Cross-Sectional Studies
Health

Vascular depression and cognition in Mexican Americans

Johnson, L. A., Large, S. E., Izurieta Munoz, H., Hall, J. & O'Bryant, S., 1 May 2019, In : Dementia and Geriatric Cognitive Disorders. 47, 1-2, p. 68-78 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Cognition
Blood Vessels
Depression
Geriatrics
Short-Term Memory
1 Citation (Scopus)

A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease

O'Bryant, S., Zhang, F., Johnson, L. A., Hall, J., Edwards, M., Grammas, P., Oh, E., Lyketsos, C. G. & Rissman, R. A., 1 Jan 2018, In : Journal of Alzheimer's disease : JAD. 66, 1, p. 97-104 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Precision Medicine
Non-Steroidal Anti-Inflammatory Agents
Alzheimer Disease
Naproxen
Proteomics